BATS:PBEE

Invesco PureBeta FTSE Emerging Markets ETF Stock Forecast, Price & News

$30.86
+0.15 (+0.49 %)
(As of 06/14/2021 12:00 AM ET)
Add
Today's Range
$30.84
$30.92
50-Day Range
$28.62
$31.05
52-Week Range
$24.50
$28.85
Volume660 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PBEE News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco PureBeta FTSE Emerging Markets ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Invesco
Fund NameInvesco PureBeta FTSE Emerging Markets ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:PBEE
Inception Date9/19/2017
Fund ManagerPeter Hubbard, Michael Jeanette, Jonathan Nixon, Tony Seisser
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkFTSE Emerging Index
CategoryBroad Equity
FocusBroad Equity
Development LevelEmerging Markets
RegionEmerging Markets

Fund Statistics

Assets Under Management$9.22 million
Average Daily Volume$819.20
Discount/Premium0.11%

ETF Expenses

Management Fee0.14%
Other Expenses0.05%
Total Expenses0.19%
Fee Waiver-0.03%
Net Expenses0.16%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Capital Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorInvesco Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market Maker

Geographic Exposure of PBEE

Currency Exposure of PBEE

Sector Exposure of PBEE

Industry Exposure of PBEE

speech bubbles
speech bubbles











Invesco PureBeta FTSE Emerging Markets ETF (BATS:PBEE) Frequently Asked Questions

What stocks does MarketBeat like better than Invesco PureBeta FTSE Emerging Markets ETF?

Wall Street analysts have given Invesco PureBeta FTSE Emerging Markets ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Invesco PureBeta FTSE Emerging Markets ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Invesco PureBeta FTSE Emerging Markets ETF's stock been impacted by COVID-19?

Invesco PureBeta FTSE Emerging Markets ETF's stock was trading at $22.0109 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PBEE stock has increased by 40.2% and is now trading at $30.8628.
View which stocks have been most impacted by COVID-19
.

What is Invesco PureBeta FTSE Emerging Markets ETF's stock symbol?

Invesco PureBeta FTSE Emerging Markets ETF trades on the BATS under the ticker symbol "PBEE."

Who are Invesco PureBeta FTSE Emerging Markets ETF's major shareholders?

Invesco PureBeta FTSE Emerging Markets ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Citadel Advisors LLC (0.00%), Jacobi Capital Management LLC (0.00%) and Jane Street Group LLC (0.00%).

Which institutional investors are buying Invesco PureBeta FTSE Emerging Markets ETF stock?

PBEE stock was purchased by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Jacobi Capital Management LLC, and Jane Street Group LLC.

How do I buy shares of Invesco PureBeta FTSE Emerging Markets ETF?

Shares of PBEE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invesco PureBeta FTSE Emerging Markets ETF's stock price today?

One share of PBEE stock can currently be purchased for approximately $30.86.


This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.